{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:47:32Z","timestamp":1791424052675,"version":"4.3.3"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T00:00:00Z","timestamp":1522800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s40618-018-0882-4","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T00:43:29Z","timestamp":1522802609000},"page":"45-52","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Decreased staging of differentiated thyroid cancer in patients with chronic lymphocytic thyroiditis"],"prefix":"10.1007","volume":"42","author":[{"given":"M.","family":"Borowczyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Janicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Dworacki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Szczepanek-Parulska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Danieluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Antonik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ka\u0142u\u017cna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Bromi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Czepczy\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"B\u0105czyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Ziemnicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Rucha\u0142a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,4]]},"reference":[{"issue":"1","key":"882_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L (2016) 2015 American Thyroid Association Management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1):1\u2013133. \n                    https:\/\/doi.org\/10.1089\/thy.2015.0020","journal-title":"Thyroid"},{"issue":"5","key":"882_CR2","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s10552-008-9260-4","volume":"20","author":"BA Kilfoy","year":"2009","unstructured":"Kilfoy BA, Zheng T, Holford TR, Han X, Ward MH, Sjodin A, Zhang Y, Bai Y, Zhu C, Guo GL, Rothman N, Zhang Y (2009) International patterns and trends in thyroid cancer incidence, 1973\u20132002. Cancer Causes Control 20(5):525\u2013531. \n                    https:\/\/doi.org\/10.1007\/s10552-008-9260-4","journal-title":"Cancer Causes Control"},{"issue":"9","key":"882_CR3","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1002\/ijc.29251","volume":"136","author":"C Vecchia La","year":"2015","unstructured":"La Vecchia C, Malvezzi M, Bosetti C, Garavello W, Bertuccio P, Levi F, Negri E (2015) Thyroid cancer mortality and incidence: a global overview. Int J Cancer 136(9):2187\u20132195. \n                    https:\/\/doi.org\/10.1002\/ijc.29251","journal-title":"Int J Cancer"},{"issue":"11","key":"882_CR4","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1089\/thy.2016.0100","volume":"26","author":"JJ Wiltshire","year":"2016","unstructured":"Wiltshire JJ, Drake TM, Uttley L, Balasubramanian SP (2016) Systematic review of trends in the incidence rates of thyroid cancer. Thyroid 26(11):1541\u20131552. \n                    https:\/\/doi.org\/10.1089\/thy.2016.0100","journal-title":"Thyroid"},{"issue":"6","key":"882_CR5","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","volume":"49","author":"J Ferlay","year":"2013","unstructured":"Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D, Bray F (2013) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 49(6):1374\u20131403. \n                    https:\/\/doi.org\/10.1016\/j.ejca.2012.12.027","journal-title":"Eur J Cancer"},{"issue":"7","key":"882_CR6","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1089\/thy.2013.0045","volume":"23","author":"LG Morris","year":"2013","unstructured":"Morris LG, Sikora AG, Tosteson TD, Davies L (2013) The increasing incidence of thyroid cancer: the influence of access to care. Thyroid 23(7):885\u2013891. \n                    https:\/\/doi.org\/10.1089\/thy.2013.0045","journal-title":"Thyroid"},{"issue":"11","key":"882_CR7","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/nrendo.2016.110","volume":"12","author":"CM Kitahara","year":"2016","unstructured":"Kitahara CM, Sosa JA (2016) The changing incidence of thyroid cancer. Nat Rev Endocrinol 12(11):646\u2013653. \n                    https:\/\/doi.org\/10.1038\/nrendo.2016.110","journal-title":"Nat Rev Endocrinol"},{"issue":"18","key":"882_CR8","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1001\/jama.295.18.2164","volume":"295","author":"L Davies","year":"2006","unstructured":"Davies L, Welch HG (2006) Increasing incidence of thyroid cancer in the United States, 1973\u20132002. JAMA 295(18):2164\u20132167. \n                    https:\/\/doi.org\/10.1001\/jama.295.18.2164","journal-title":"JAMA"},{"issue":"6","key":"882_CR9","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1210\/jc.2008-2291","volume":"94","author":"SH Golden","year":"2009","unstructured":"Golden SH, Robinson KA, Saldanha I, Anton B, Ladenson PW (2009) Clinical review: prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review. J Clin Endocrinol Metab 94(6):1853\u20131878. \n                    https:\/\/doi.org\/10.1210\/jc.2008-2291","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"882_CR10","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1089\/thy.2007.0234","volume":"18","author":"S Benvenga","year":"2008","unstructured":"Benvenga S, Trimarchi F (2008) Changed presentation of Hashimoto\u2019s thyroiditis in North-Eastern Sicily and Calabria (Southern Italy) based on a 31-year experience. Thyroid 18(4):429\u2013441. \n                    https:\/\/doi.org\/10.1089\/thy.2007.0234","journal-title":"Thyroid"},{"key":"882_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/bmb\/ldr030","volume":"99","author":"MP Vanderpump","year":"2011","unstructured":"Vanderpump MP (2011) The epidemiology of thyroid disease. Br Med Bull 99:39\u201351. \n                    https:\/\/doi.org\/10.1093\/bmb\/ldr030","journal-title":"Br Med Bull"},{"issue":"2","key":"882_CR12","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s12020-012-9703-2","volume":"42","author":"DS McLeod","year":"2012","unstructured":"McLeod DS, Cooper DS (2012) The incidence and prevalence of thyroid autoimmunity. Endocrine 42(2):252\u2013265. \n                    https:\/\/doi.org\/10.1007\/s12020-012-9703-2","journal-title":"Endocrine"},{"issue":"3","key":"882_CR13","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1006\/clin.1997.4412","volume":"84","author":"DL Jacobson","year":"1997","unstructured":"Jacobson DL, Gange SJ, Rose NR, Graham NM (1997) Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 84(3):223\u2013243","journal-title":"Clin Immunol Immunopathol"},{"issue":"6","key":"882_CR14","first-page":"537","volume":"30","author":"R Virchow","year":"1956","unstructured":"Virchow R (1956) Standpoints in scientific medicine, 1877. Bull Hist Med 30(6):537\u2013543","journal-title":"Bull Hist Med"},{"issue":"9255","key":"882_CR15","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","volume":"357","author":"F Balkwill","year":"2001","unstructured":"Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357(9255):539\u2013545. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(00)04046-0","journal-title":"Lancet"},{"issue":"4","key":"882_CR16","first-page":"1119","volume":"32","author":"AL Franks","year":"2012","unstructured":"Franks AL, Slansky JE (2012) Multiple associations between a broad spectrum of autoimmune diseases, chronic inflammatory diseases and cancer. Anticancer Res 32(4):1119\u20131136","journal-title":"Anticancer Res"},{"issue":"2","key":"882_CR17","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1089\/thy.2012.0554","volume":"23","author":"P Caturegli","year":"2013","unstructured":"Caturegli P, De Remigis A, Chuang K, Dembele M, Iwama A, Iwama S (2013) Hashimoto\u2019s thyroiditis: celebrating the centennial through the lens of the Johns Hopkins hospital surgical pathology records. Thyroid 23(2):142\u2013150. \n                    https:\/\/doi.org\/10.1089\/thy.2012.0554","journal-title":"Thyroid"},{"issue":"3","key":"882_CR18","doi-asserted-by":"publisher","first-page":"e55450","DOI":"10.1371\/journal.pone.0055450","volume":"8","author":"A Latina","year":"2013","unstructured":"Latina A, Gullo D, Trimarchi F, Benvenga S (2013) Hashimoto\u2019s thyroiditis: similar and dissimilar characteristics in neighboring areas. Possible implications for the epidemiology of thyroid cancer. PLoS One 8(3):e55450. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0055450","journal-title":"PLoS One"},{"issue":"2","key":"882_CR19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.14310\/horm.2002.1261","volume":"9","author":"U Feldt-Rasmussen","year":"2010","unstructured":"Feldt-Rasmussen U, Rasmussen AK (2010) Autoimmunity in differentiated thyroid cancer: significance and related clinical problems. Hormones (Athens) 9(2):109\u2013117","journal-title":"Hormones (Athens)"},{"key":"882_CR20","doi-asserted-by":"publisher","first-page":"387062","DOI":"10.4061\/2011\/387062","volume":"2011","author":"LL Cunha","year":"2011","unstructured":"Cunha LL, Ferreira RC, Marcello MA, Vassallo J, Ward LS (2011) Clinical and pathological implications of concurrent autoimmune thyroid disorders and papillary thyroid cancer. J Thyroid Res 2011:387062. \n                    https:\/\/doi.org\/10.4061\/2011\/387062","journal-title":"J Thyroid Res"},{"issue":"3","key":"882_CR21","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1530\/EJE-12-0903","volume":"168","author":"JH Lee","year":"2013","unstructured":"Lee JH, Kim Y, Choi JW, Kim YS (2013) The association between papillary thyroid carcinoma and histologically proven Hashimoto\u2019s thyroiditis: a meta-analysis. Eur J Endocrinol 168(3):343\u2013349. \n                    https:\/\/doi.org\/10.1530\/EJE-12-0903","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"882_CR22","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1530\/EJE-14-1046","volume":"173","author":"PK Iliadou","year":"2015","unstructured":"Iliadou PK, Effraimidis G, Konstantinos M, Grigorios P, Mitsakis P, Patakiouta F, Pazaitou-Panayiotou K (2015) Chronic lymphocytic thyroiditis is associated with invasive characteristics of differentiated thyroid carcinoma in children and adolescents. Eur J Endocrinol 173(6):827\u2013833. \n                    https:\/\/doi.org\/10.1530\/EJE-14-1046","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"882_CR23","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1001\/archsurg.1955.01270080137023","volume":"70","author":"ME Dailey","year":"1955","unstructured":"Dailey ME, Lindsay S, Skahen R (1955) Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland. AMA Arch Surg 70(2):291\u2013297","journal-title":"AMA Arch Surg"},{"issue":"7","key":"882_CR24","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1089\/thy.2013.0588","volume":"24","author":"R Paparodis","year":"2014","unstructured":"Paparodis R, Imam S, Todorova-Koteva K, Staii A, Jaume JC (2014) Hashimoto\u2019s thyroiditis pathology and risk for thyroid cancer. Thyroid 24(7):1107\u20131114. \n                    https:\/\/doi.org\/10.1089\/thy.2013.0588","journal-title":"Thyroid"},{"issue":"3","key":"882_CR25","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.bjorl.2014.04.006","volume":"81","author":"FM Girardi","year":"2015","unstructured":"Girardi FM, Barra MB, Zettler CG (2015) Papillary thyroid carcinoma: does the association with Hashimoto\u2019s thyroiditis affect the clinicopathological characteristics of the disease? Braz J Otorhinolaryngol 81(3):283\u2013287. \n                    https:\/\/doi.org\/10.1016\/j.bjorl.2014.04.006","journal-title":"Braz J Otorhinolaryngol"},{"issue":"4","key":"882_CR26","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3349\/ymj.2014.55.4.879","volume":"55","author":"HG Kim","year":"2014","unstructured":"Kim HG, Kim EK, Han KH, Kim H, Kwak JY (2014) Pathologic spectrum of lymphocytic infiltration and recurrence of papillary thyroid carcinoma. Yonsei Med J 55(4):879\u2013885. \n                    https:\/\/doi.org\/10.3349\/ymj.2014.55.4.879","journal-title":"Yonsei Med J"},{"issue":"12","key":"882_CR27","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.1210\/jcem.80.12.8530576","volume":"80","author":"S Matsubayashi","year":"1995","unstructured":"Matsubayashi S, Kawai K, Matsumoto Y, Mukuta T, Morita T, Hirai K, Matsuzuka F, Kakudoh K, Kuma K, Tamai H (1995) The correlation between papillary thyroid carcinoma and lymphocytic infiltration in the thyroid gland. J Clin Endocrinol Metab 80(12):3421\u20133424. \n                    https:\/\/doi.org\/10.1210\/jcem.80.12.8530576","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"882_CR28","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1210\/jc.2013-1309","volume":"98","author":"S Dvorkin","year":"2013","unstructured":"Dvorkin S, Robenshtok E, Hirsch D, Strenov Y, Shimon I, Benbassat CA (2013) Differentiated thyroid cancer is associated with less aggressive disease and better outcome in patients with coexisting Hashimotos thyroiditis. J Clin Endocrinol Metab 98(6):2409\u20132414. \n                    https:\/\/doi.org\/10.1210\/jc.2013-1309","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"882_CR29","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1210\/jcem.84.2.5443","volume":"84","author":"KC Loh","year":"1999","unstructured":"Loh KC, Greenspan FS, Dong F, Miller TR, Yeo PP (1999) Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 84(2):458\u2013463. \n                    https:\/\/doi.org\/10.1210\/jcem.84.2.5443","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"882_CR30","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1089\/thy.1998.8.197","volume":"8","author":"K Kashima","year":"1998","unstructured":"Kashima K, Yokoyama S, Noguchi S, Murakami N, Yamashita H, Watanabe S, Uchino S, Toda M, Sasaki A, Daa T, Nakayama I (1998) Chronic thyroiditis as a favorable prognostic factor in papillary thyroid carcinoma. Thyroid 8(3):197\u2013202. \n                    https:\/\/doi.org\/10.1089\/thy.1998.8.197","journal-title":"Thyroid"},{"issue":"6","key":"882_CR31","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1067\/msy.2099.101431","volume":"126","author":"B Singh","year":"1999","unstructured":"Singh B, Shaha AR, Trivedi H, Carew JF, Poluri A, Shah JP (1999) Coexistent Hashimoto\u2019s thyroiditis with papillary thyroid carcinoma: impact on presentation, management, and outcome. Surgery 126(6):1070\u20131076 (discussion 1076\u20131077b)","journal-title":"Surgery"},{"issue":"5","key":"882_CR32","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1007\/s002680020165","volume":"25","author":"E Kebebew","year":"2001","unstructured":"Kebebew E, Treseler PA, Ituarte PH, Clark OH (2001) Coexisting chronic lymphocytic thyroiditis and papillary thyroid cancer revisited. World J Surg 25(5):632\u2013637. \n                    https:\/\/doi.org\/10.1007\/s002680020165","journal-title":"World J Surg"},{"issue":"4","key":"882_CR33","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/j.1365-2265.2009.03537.x","volume":"71","author":"EY Kim","year":"2009","unstructured":"Kim EY, Kim WG, Kim WB, Kim TY, Kim JM, Ryu JS, Hong SJ, Gong G, Shong YK (2009) Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma. Clin Endocrinol (Oxf) 71(4):581\u2013586. \n                    https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03537.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"882_CR34","doi-asserted-by":"publisher","first-page":"883","DOI":"10.3346\/jkms.2012.27.8.883","volume":"27","author":"JS Jeong","year":"2012","unstructured":"Jeong JS, Kim HK, Lee CR, Park S, Park JH, Kang SW, Jeong JJ, Nam KH, Chung WY, Park CS (2012) Coexistence of chronic lymphocytic thyroiditis with papillary thyroid carcinoma: clinical manifestation and prognostic outcome. J Korean Med Sci 27(8):883\u2013889. \n                    https:\/\/doi.org\/10.3346\/jkms.2012.27.8.883","journal-title":"J Korean Med Sci"},{"key":"882_CR35","volume-title":"World health organization classification of tumours. Pathology and genetics of tumours of endocrine organs","author":"RA DeLellis","year":"2004","unstructured":"DeLellis RA, Lloyd RV, Heitz PU, Eng C (2004) World health organization classification of tumours. Pathology and genetics of tumours of endocrine organs. IARC Press, Lyon"},{"key":"882_CR36","unstructured":"Focal lymphocytic thyroiditis. PathologyOutlines.com website. \n                    http:\/\/www.pathologyoutlines.com\/topic\/thyroidfocallymphocytic.html\n                    \n                  . Accessed 3 Sept 2017"},{"issue":"6","key":"882_CR37","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","volume":"17","author":"SB Edge","year":"2010","unstructured":"Edge SB, Compton CC (2010) The American Joint Committee on cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17(6):1471\u20131474. \n                    https:\/\/doi.org\/10.1245\/s10434-010-0985-4","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"882_CR38","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.tem.2014.09.001","volume":"25","author":"M Ehlers","year":"2014","unstructured":"Ehlers M, Schott M (2014) Hashimoto\u2019s thyroiditis and papillary thyroid cancer: are they immunologically linked? Trends Endocrinol Metab 25(12):656\u2013664. \n                    https:\/\/doi.org\/10.1016\/j.tem.2014.09.001","journal-title":"Trends Endocrinol Metab"},{"issue":"8","key":"882_CR39","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.3109\/0284186X.2011.602109","volume":"50","author":"D Ahn","year":"2011","unstructured":"Ahn D, Heo SJ, Park JH, Kim JH, Sohn JH, Park JY, Park SK, Park J (2011) Clinical relationship between Hashimoto\u2019s thyroiditis and papillary thyroid cancer. Acta Oncol 50(8):1228\u20131234. \n                    https:\/\/doi.org\/10.3109\/0284186X.2011.602109","journal-title":"Acta Oncol"},{"issue":"13","key":"882_CR40","first-page":"1910","volume":"18","author":"HY Bircan","year":"2014","unstructured":"Bircan HY, Koc B, Akarsu C, Demiralay E, Demirag A, Adas M, Alis H, Kemik O (2014) Is Hashimoto\u2019s thyroiditis a prognostic factor for thyroid papillary microcarcinoma? Eur Rev Med Pharmacol Sci 18(13):1910\u20131915","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"6","key":"882_CR41","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1111\/j.1365-2265.2012.04482.x","volume":"77","author":"LL Cunha","year":"2012","unstructured":"Cunha LL, Morari EC, Guihen AC, Razolli D, Gerhard R, Nonogaki S, Soares FA, Vassallo J, Ward LS (2012) Infiltration of a mixture of immune cells may be related to good prognosis in patients with differentiated thyroid carcinoma. Clin Endocrinol (Oxf) 77(6):918\u2013925. \n                    https:\/\/doi.org\/10.1111\/j.1365-2265.2012.04482.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"15","key":"882_CR42","first-page":"2824","volume":"19","author":"S Medenica","year":"2015","unstructured":"Medenica S, Radojevic N, Stojkovic M, Nedeljkovic-Beleslin B, Savic S, Ciric J, Trbojevic B, Zarkovic M (2015) Autoimmunity and thyrotropin level in developing thyroid malignancy. Eur Rev Med Pharmacol Sci 19(15):2824\u20132829","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"4","key":"882_CR43","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S0025-7125(16)32354-9","volume":"56","author":"WM McConahey","year":"1972","unstructured":"McConahey WM (1972) Hashimoto\u2019s thyroiditis. Med Clin North Am 56(4):885\u2013896","journal-title":"Med Clin North Am"},{"issue":"1","key":"882_CR44","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jss.2007.09.020","volume":"150","author":"D Repplinger","year":"2008","unstructured":"Repplinger D, Bargren A, Zhang YW, Adler JT, Haymart M, Chen H (2008) Is Hashimoto\u2019s thyroiditis a risk factor for papillary thyroid cancer? J Surg Res 150(1):49\u201352. \n                    https:\/\/doi.org\/10.1016\/j.jss.2007.09.020","journal-title":"J Surg Res"},{"issue":"2\u20133","key":"882_CR45","doi-asserted-by":"publisher","first-page":"J109","DOI":"10.1016\/j.jaut.2011.10.003","volume":"38","author":"OL Quintero","year":"2012","unstructured":"Quintero OL, Amador-Patarroyo MJ, Montoya-Ortiz G, Rojas-Villarraga A, Anaya JM (2012) Autoimmune disease and gender: plausible mechanisms for the female predominance of autoimmunity. J Autoimmun 38(2\u20133):J109\u2013J119. \n                    https:\/\/doi.org\/10.1016\/j.jaut.2011.10.003","journal-title":"J Autoimmun"},{"issue":"2","key":"882_CR46","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1210\/jcem.75.2.1322431","volume":"75","author":"H Kimura","year":"1992","unstructured":"Kimura H, Yamashita S, Namba H, Tominaga T, Tsuruta M, Yokoyama N, Izumi M, Nagataki S (1992) Interleukin-1 inhibits human thyroid carcinoma cell growth. J Clin Endocrinol Metab 75(2):596\u2013602. \n                    https:\/\/doi.org\/10.1210\/jcem.75.2.1322431","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-018-0882-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-018-0882-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-018-0882-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T03:34:12Z","timestamp":1554348852000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-018-0882-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,4]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["882"],"URL":"https:\/\/doi.org\/10.1007\/s40618-018-0882-4","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,4]]},"assertion":[{"value":"21 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors report no potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Bioethical Committee of Poznan University of Medical Sciences. All procedures performed in study involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study for patients\u2019 study participation and publication of identifying information and images.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}